Design, synthesis, and evaluation of N-benzylpyrrolidine and 1,3,4-oxadiazole as multitargeted hybrids for the treatment of Alzheimer’s disease
- 1 June 2021
- journal article
- research article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 111, 104922
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Structures of Human Acetylcholinesterase in Complex with Pharmacologically Important LigandsJournal of Medicinal Chemistry, 2012
- Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer's disease: Implications for early intervention and therapeuticsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- The role of CREB signaling in Alzheimer’s disease and other cognitive disordersReviews in the Neurosciences, 2011
- Soluble βamyloid1‐42: a critical player in producing behavioural and biochemical changes evoking depressive‐related state?British Journal of Pharmacology, 2010
- The β-Secretase Enzyme BACE in Health and Alzheimer's Disease: Regulation, Cell Biology, Function, and Therapeutic PotentialThe Journal of Neuroscience, 2009
- Morris water maze: procedures for assessing spatial and related forms of learning and memoryNature Protocols, 2006
- Residues 17–20 and 30–35 of beta‐amyloid play critical roles in aggregationJournal of Neuroscience Research, 2003
- Oxidative stress in Alzheimer’s diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2000
- Acetylcholinesterase Accelerates Assembly of Amyloid-β-Peptides into Alzheimer's Fibrils: Possible Role of the Peripheral Site of the EnzymeNeuron, 1996
- The Determination of Enzyme Dissociation ConstantsJournal of the American Chemical Society, 1934